Navigation Links
Lafayette General Medical Center is the First Hospital in Louisiana to Use Genetic-Based Technology to Test for Respiratory Disease
Date:1/14/2009

LAFAYETTE, La., Jan. 14 /PRNewswire/ -- Lafayette General Medical Center (LGMC) announced today it is the first hospital in Louisiana to use a proprietary molecular genetic technology, which includes specific tests that more accurately diagnose respiratory infectious diseases. This technology, called Target Enriched Multiplex Polymerase Chain Reaction (Tem-PCR), allows physicians to test for multiple infections, both viral and bacterial, in as little as four hours. This faster and more precise testing helps physicians create efficient treatment protocols which generally improve clinical outcomes and decrease length of stay. Tem-PCR testing is provided by Diatherix Laboratories Inc., (www.diagnostixna.com), located in the Hudson-Alpha Institute for Biotechnology in Huntsville, Ala.

"This is highly advanced testing technology," said David Callecod, chief executive officer of LGMC. "Complex respiratory infections are a major challenge faced by hospitals. For the first time, using a revolutionary nasal wash test, our physicians will be able to quickly and more accurately diagnose a respiratory infection as well as co-infections, which may go undetected using more traditional testing. Our physicians will be able to simultaneously treat both primary and co-infections resulting in more positive clinical outcomes."

"Lafayette General is leading the way in providing patients with the benefits of genetic science," said Dennis Grimaud, chief executive officer of Diatherix Laboratories. "Hospitals throughout Louisiana and across the country are inundated with patients suffering from various types of respiratory diseases, all of which can be more cost-effectively and rapidly identified as well as more accurately coded using this new and exciting technology. The impact on the costs of treatment and the clinical outcomes is significant."

As the largest, full-service, acute-care medical center in the nine parishes of Acadiana, Lafayette General Medical Center's mission is to improve, maintain and restore the health of people in the communities we serve. LGMC is a community-owned hospital, and any profits are reinvested in the hospital for purchasing unsurpassed technology, maintaining a highly trained staff and adding new and improved services.

Diatherix Laboratories Inc. is located in the Hudson-Alpha Institute for Biotechnology in Huntsville, Ala. Diatherix operates as an independent clinical laboratory providing advanced multiplex molecular diagnostic services such as Tem-PCR to identify infectious disease to hospitals and the healthcare community. Diagnostic Network Alliance (DNA) (www.diagnostixna.com), with representative offices throughout the United States, is the exclusive US distributor for Diatherix Laboratory. DNA and Diatherix Laboratories share corporate administrative headquarters in Brentwood, Tenn.


'/>"/>
SOURCE Diatherix Laboratories Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
2. Sinovac Announces Postponement of Annual General Meeting
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
5. CryoLife Names Philip Theodore as Vice President, General Counsel
6. 3SBio Inc. to Hold Annual General Meeting
7. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
8. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
9. Elbit Medical Imaging Ltd. Announces Results of Its Annual General Meeting
10. Symmetry Medical to Provide Third Quarter 2007 General Business Update on November 7, 2007
11. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... (PRWEB) , ... August 14, 2017 , ... The ... Trials event, which will take place on September 6, 2017 at the Marriott ... MD , Head of Experimental Medicine, Informatics, and Regulatory Strategy, Pfizer Innovative Research Lab, ...
(Date:8/11/2017)... ... August 11, 2017 , ... A staple in the community for more than ... important key elements including a new digital marketing strategy and updated logo. , As ... Miller has partnered with the South Texas Blood & Tissue Center for the month ...
(Date:8/11/2017)... ... August 11, 2017 , ... “There is an increasing ... alternatives to synthetic ingredients,” said Matt Hundt, President of Third Wave Bioactives. “Combining ... presence and know-how of Biorigin will allow us to bring truly novel fermented ...
(Date:8/10/2017)... ... August 09, 2017 , ... Teachers from three ... From August 14th through the 16th, the University City Science Center will kick ... of 2016, provides Philadelphia-based middle school educators an opportunity for professional development related ...
Breaking Biology Technology:
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
(Date:3/29/2017)... CHICAGO , March 29, 2017  higi, the ... ecosystem in North America , today ... Partners and the acquisition of EveryMove. The new investment ... extensive set of tools to transform population health activities ... and lifestyle data. higi collects and secures ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):